logo
[breadcrumb_custom]

Tag: Cullinan Oncology Inc. (NASDAQ:CGEM)

HCCC Stock
Finance

Cullinan Oncology Inc (CGEM) Stock: A Year of Highs and Lows

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Cullinan Oncology Inc’s current trading price is -16.97% away from its 52-week high, while its distance from the 52-week low is 113.87%. The stock’s price range over this period has fluctuated between $7.64 and $19.68. The company, operating within the financial sector, had a trading volume of approximately 0.47 million for the day, which was noticeably higher than the average daily share volume of 0.41 million over the last 3 months. Cullinan Oncology Inc saw a rather

ZM Stock
Finance

Anchoring Your Portfolio: Is CGEM Stock a Safe Harbor?

Cullinan Oncology Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $19.68 on 02/12/24 and the lowest value was $7.64 on 12/12/23. 52-week price history of CGEM Stock A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Cullinan Oncology Inc’s current trading price is -16.92% away from its 52-week high, while its distance from the 52-week low is 114.01%. The stock’s price range during this period has spanned from $7.64 to $19.68. In the Healthcare sector, the Cullinan Oncology Inc’s shares surpassed a

Finance

Cullinan Oncology Inc (CGEM) Stock: Navigating a Year of Stock Volatility

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Cullinan Oncology Inc’s current trading price is 6.91% away from its 52-week high, while its distance from the 52-week low is 92.28%. The stock’s price range for this period has been between $7.64 and $13.74 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.65 million for the day, a number notably higher than the average daily volume of 0.22 million over the last three months. Cullinan Oncology Inc experienced a rather steady